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Abstract
Objective: To evaluate the inflammatory pattern in maternal circulation, amniotic cavity, cervix and vagina from women
with preterm prelabor rupture of membranes (PPROM) considering the occurrence of microbial invasion of the amniotic
cavity (MIAC).
Methodology: A prospective study was performed in 58 women with PPROM before 34+0 weeks of gestational age.
Twenty-six proteins were analyzed by a multiple immunoassay in samples of amniotic fluid, serum, cervix and vagina.
Association of an inflammatory response in the invasive and non-invasive samples with MIAC was investigated.
Results: The rate of MIAC was 36.2% (21/58). Both amniotic fluid IL-6 and cervical C-reactive protein (CRP) showed to be
independent predictors of MIAC. A cut-off level of cervical CRP$1836 pg/mL showed a detection rate of 75%, false positive
rate of 19% and positive and negative predictive values to predict MIAC of 67% and 87%, respectively. There were no
independent biomarkers of MIAC either in the serum or vaginal compartment.
Conclusion: A cervical inflammatory response mediated by CRP was observed in PPROM women with MIAC. Evaluation of
serum or vaginal samples did not add valuable information regarding the outcome evaluated.
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Introduction
Preterm prelabor rupture of membranes (PPROM) is respon-
sible for approximately one-third of spontaneous preterm deliver-
ies and for a substantial proportion of neonatal morbidity and
mortality in relation to gestational age and the risk of infection [1].
Several inflammatory biomarkers alone or in combination have
been previously reported as predictors of microbial invasion of the
amniotic cavity (MIAC) in the amniotic fluid compartment in
women with preterm labor either with intact membranes (PTL) or
with PPROM [2–9]. However, there are few references about the
role of these inflammatory biomarkers in non-invasive samples,
such as serum [5,10], cervix [11–13] or vagina [14], with most
being focused on women with PTL.
Remarkably, few studies have been carried out in the subgroup
of women with PPROM with poor predictive capacity to predict
MIAC by non-invasive fluids [10,12]. Few information is available
on this topic and studies are needed to determine whether the
inflammatory status in non-invasive samples predict either the
inflammatory/infectious status in the amniotic cavity. Further-
more, the identification of non-invasive inflammatory biomarkers
in women with PPROM is relevant from a clinical point of view,
considering not only the risk but the difficulty of an invasive
procedure to obtain amniotic fluid in these women, most of them
complicated with oligohydramnios.
Therefore, the aim of this study was to investigate the pattern of
inflammation not only in the amniotic fluid compartment but most
interesting in non-invasive compartments as serum, cervix and
vagina in women with PPROM using a panel of inflammatory
proteins determined by a multiple immunoassay and to evaluate its
relationship with MIAC.
Material and Methods
Study population
From September 2005 to June 2008, women with a diagnosis of
PPROM before 34.0 weeks admitted to the Maternal-Fetal
Medicine Department at the Hospital Clinic in Barcelona were
considered eligible for the study. PPROM was defined as leakage
of amniotic fluid preceding the onset of uterine contractions.
PPROM was diagnosed by a sterile speculum examination to
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identify pooling of amniotic fluid in the vagina and was confirmed
by alkaline pH in the absence of vaginal infection. Gestational age
was calculated based on the crown-rump length at first trimester
ultrasound. Multiple pregnancies, structural/chromosomal anom-
alies, clinical signs of chorioamnionitis [15], vaginal bleeding at
admission or those cases where amniocentesis was not possible
(i.e.anhydramnios) were excluded.
According to our standard protocol, blood sampling and a
transabdominal amniocentesis to rule out signs of chorioamnio-
nitis, cervical cultures for the identification of bacteria and fungi,
and transvaginal cervical length by ultrasound, were performed at
admission. The amniocentesis was performed before the admin-
istration of corticosteroids or antibiotics.
Amniotic fluid cultures for aerobic, anaerobic bacteria and
genital mycoplasma, as well as glucose concentration were
performed immediately after collection and their results were
available for clinical management. A complete course of antenatal
steroids, betamethasone 12 mg intramuscular injection with two
doses given 24 h apart, was administered when PPROM occurred
from 24.0 to 34.0 weeks. Tocolysis was only considered if uterine
contractions in the absence of clinical chorioamnionitis, abruption
placentae and fetal compromise. Prophylactic parenteral broad-
spectrum antibiotics were given for a period of 5 days. The
antibiotic regimen of choice in our institution at that time was
parenteral ampicillin 1 g every 6 h and gentamycin 80 mg every
8 h. In line with other clinical management guidelines1, labor was
induced if PPROM occurred at or beyond 34.0 weeks. If PPROM
occurred before 31.0 weeks, expectant management was per-
formed. According to our local protocol at that time, at or beyond
31.0 weeks of gestation, labor was induced if pulmonary maturity
was documented.
Women with a positive cervical culture were correctly treated
orally or vaginally according to the microorganism isolated. MIAC
was defined as a positive amniotic fluid culture. Women with
MIAC were treated with parenteral antibiotics during 10 days
according to the antibiogram of the microorganism isolated.
Maternal and fetal status were closely monitored for signs of
chorioamnionitis, labor and/or fetal compromise. Induction of
labor was indicated based on virulence of the microorganism,
gestational age, maternal or fetal clinical signs of chorioamnionitis.
Spontaneous preterm delivery was defined as delivery following
spontaneous labor.
To identify inflammatory biomarkers in non-invasive samples
from the cervical and vaginal compartment, cervical and vagina
mucus were obtained separately using Cytobrush swabs (Cyto-
brush Plus GT; Medscan Medical AB) from the external cervical
os and from the 6 middle third of the vagina, respectively after
amniocentesis sampling. Each Cytobrush was submerged in
1.0 ml of NaCl (9 mg/ml) and kept at 4uC until processing,
which occurred within 2 hours. Cervical, vaginal and the
remaining amniotic fluid and serum samples were centrifuged at
4000 rpm at 4uC for 10 minutes and stored at 280uC until
analysis.
Twenty-six proteins were simultaneously analyzed by a multiple
immunoassay in amniotic fluid, maternal serum, cervix and
vagina. Details about the methodology used for proteomic
biomarkers determinations and threshold used were available in
a supplemental appendix. An interim analysis was planned with
the first 25 serum and amniotic fluid samples. Main variable
outcome was MIAC.
Ethics statement
Written informed consent was obtained from all subjects. The
Institutional Review Board approved the collection and use of
these samples for research purposes (Ethics Committee of Hospital
Clinic of Barcelona 2005/56).
Statistical methods
Statistical analyses were performed using SPSS 19.0 for
Windows XP OS (SPSS Inc., USA). Demographic and clinical
characteristics were compared using the nonparametric Mann-
Whitney U test and the results are presented as median (range).
Categorical variables were compared using linear by linear
association Chi-square and are presented as numbers (%). All
significant continuous variables were entered into a logistic
regression with a forward selection. Receiver operator curves
were constructed to determine the best cut-off value to predict the
outcome. Differences were considered statistically significant with
a p,0.05 with two-sided alternative hypotheses.
Results
Over the study period, 58 women met the inclusion criteria and
accepted to be included in the study. Distribution according the
occurrence of MIAC in the different non-invasive compartments is
shown in Figure 1.
The maternal and neonatal characteristics are summarized in
Table 1. Gestational age at PPROM was less than 24.0 weeks in 8
(14%) women; between 24.0 and 27.6 weeks in 16 (27%) women;
between 28.0 and 31.6 weeks in 18 (31%) women and beyond 32.0
weeks in 16 (27%) women. Gestational age at sampling and
amniotic fluid glucose was significantly lower in women with
Figure 1. Clinical distribution of the study population.
doi:10.1371/journal.pone.0085277.g001
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MIAC than without. These two significant variables were entered
in a logistic regression with a forward selection with the significant
invasive and non-invasive inflammatory proteins to assess the
independent biomarker of MIAC.
The overall rate of MIAC was 36.2% (21/58). The most
common microorganism isolated from amniotic fluid was Urea-
plasma urealyticum (n = 10). Other microorganisms isolated were
Mycoplasma hominis (n = 1), Streptococcus agalactiae (n = 1), Streptococcus
viridans (n = 3), Streptococcus pneumoniae and Haemophylus influenzae
(n = 1), Escherichia coli (n = 1), Candida albicans (n = 1), Fusobacterium
(n = 1), Gardnerella vaginalis (n = 1) and Candida glabrata (n = 1).
Three out of 21 women with MIAC presented a positive
cervical culture at admission: Candida albicans and Escherichia coli
(n = 1), Candida glabrata (n = 1), and Gardnerella vaginalis (n = 1). Six
out of 37 women without MIAC presented a positive cervical
culture by Candida albicans and Escherichia coli (n = 3) and Gardnerella
vaginalis (n = 3).
From 26 biomarkers evaluated, maternal serum interferon-
(IFN)-c and granulocyte macrophage colony stimulating factor
(GM-CSF) and amniotic fluid, cervical and vaginal Interleukin
(IL)-17 and tumor necrosis factor (TNF)-a had undetectable levels
in more than 50% of the samples and were subsequently excluded
from further analyses.
The univariate analysis of the serum samples in the first 25
women revealed that there were no significant differences in none
of the inflammatory proteins of interest in women with MIAC
(Table S1). Therefore, remaining maternal blood samples were not
analyzed. From then onwards, only samples simultaneously
obtained from the amniotic fluid, the cervix and the vagina were
considered for analysis. Amniotic fluid levels of IL-8, C-reactive
protein (CRP), regulated on activation normal T-expressed and
secreted (RANTES), brain-derived neurotropic factor (BDNF),
IFN-c, GM-CSF, macrophage inflammatory protein-1a (MIP-1a),
IL-6, IL-10, IL-1b, TNF-b, triggering receptor expressed on
myeloid cells-1 (TREM-1), neutropin-3 (NT3), and soluble TNF
receptor-1 (sTNF-R1) were significantly higher in women with
MIAC than without (Table 2). However, when we considered
other significant clinical variables (gestational age at sampling and
amniotic fluid glucose) only amniotic fluid IL-6 (OR 95%
Confidential interval (CI): 1.002 (1.000–1.003); p 0.019) remained
independent predictor of MIAC.
Cervical levels CRP, RANTES, IL-1b, TREM-1 and NT3 were
significantly higher in women with MIAC than without but only
cervical CRP (OR 95% CI: 1.001 (1.000–1.002); p 0.04) showed
to be an independent biomarker in the multivariate analysis.
Receiver operator curve (ROC) analysis demonstrated that the
best cut-off value for cervical CRP to predict MIAC was 1836 pg/
mL (area under the curve 0.77, 95% Confidence Interval: 0.59–
0.89) with a sensitivity of 75%, specificity of 81%, positive
predictive value of 67%, negative predictive value of 87% and
positive and negative likelihood ratio of 4.0 and 20.307,
respectively.
Finally, although vaginal CRP levels were significantly higher in
women with MIAC than without, only gestational age at sampling
remained significantly independent (OR 0.680, 95% CI (0.480–
0.962); p 0.29) when considered all significant variables in the
multivariate analysis.
Discussion
The main finding of the study was the existence of an
inflammatory response in the cervical compartment mediated by
CRP in PPROM women with MIAC but not in the serum and
vaginal compartment.
In line with previously published in preterm labor with or
without membranes rupture [2,3,5–8,16,17], a significant inflam-
matory response in the amniotic fluid was observed in response to
MIAC, being IL-6 its best predictor.
Regarding non-invasive compartments, a different inflammato-
ry pattern was observed only in the cervical compartment in
women with MIAC compared to women without. In line with
previously reported with cervical IL-6 [12], the presence of a high
concentration of CRP in the cervical compartment accurately
reflected the presence of an inflammatory/infectious status in the
amniotic cavity with a high detection rate to predict MIAC of
75%, a relatively low FP rate (13%) and a high PPV (75%). These
findings are clinically relevant due to the feasibility and
accessibility of the assessment of cervical mucus in clinical practice
and support the notion that a single test would be useful to provide
rapid prediction of MIAC in patients with PPROM without
clinical symptoms of chorioamnionitis.
Table 1. Maternal characteristics according to MIAC in women with PPROM.
MIAC (n= 21) Absence MIAC (n=37) p
Maternal age (years) 32 (23-43) 33 (20-43) 0.904
Nulliparity 14 (66) 14 (38) 0.384
Gestational age at sampling
, 28.0 weeks 7 (33) 5 (13) 0.088
28.0-32.0 weeks 3 (14) 8 (22) 0.220
. 32.0 1 7 0.659
Cervical length (mm) 19 (1-45) 27 (0-48) 0.255
Positive cervical culture 3 (14%) 6 (16%) 0.638
Amniotic fluid glucose (mg/dL) 10 (0-45) 28 (1-64) 0.000
Gestational age at delivery (weeks) 29.4 (20.2-33.5) 33 (28.3-34) 0.000
Spontaneous delivery # 7 days 4 (19) 7 (19) 1.000
Birth weight (g) 1160 (348-2250) 1930 (1070-3050) 0.000
The continuous variables were compared using a non parametric Mann-Whitney U test presented as median (range). The categorical variables were compared using the
Fisher’s exact test and are presented as the number (%).
doi:10.1371/journal.pone.0085277.t001
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On the other hand, we did not find a different expression of
inflammatory proteins in response to MIAC either in the vaginal
or in the serum compartment, suggesting that these non-invasive
compartments do not seem to translate the inflammatory status of
the amniotic cavity. This is in contrast to the findings of Hitti et al.
[14] who in a subgroup of women with PTL with intact
membranes, identified proteins in the vaginal fluid compartment
capable of discriminating between women with and without
MIAC. Differences between the two populations explored (PTL
vs. PPROM) and different proteomic biomarkers analysed could
partially explain why differences in the proteomic profile identified
in vagina by Hitti et al. [14], were not found in our study. In the
serum compartment, preliminary data reported by Gravett et al.
[5] suggested that proteomic biomarkers such as calgranulin B and
IGFBP-1 might be detectable in maternal serum. When 26
inflammatory proteins were simultaneously evaluated using
multiple immunoassay in a cohort of PPROM women with
MIAC, a low systemic inflammatory response was observed by our
group, mediated only by maternal serum IL-18, IL-1b and MCP-1
[10]. Despite a similar approach was performed in the current
study, we did not find any significant differences in the serum
compartment.
The main strength of the study was the assessment of biological
samples (maternal serum, cervix and vagina) obtained simulta-
neously to amniotic fluid sampling. This may provide better
knowledge of the inflammatory response to infection in the
different compartments at the same time. Furthermore, to our
knowledge, there are no previous studies evaluating the inflam-
matory process using such a broad panel of biomarkers in non-
invasive samples in PPROM women.
Our study also presents some limitations. First, it was performed
in a single institution thereby limiting the sample size. Secondly,
although amniotic fluid was collected in all women, not all non-
invasive samples (serum, cervix and vagina) were assessed in all of
them limiting again the sample size. And finally, short and long
term neonatal outcomes were not considered and therefore, the
impact on neonatal outcomes regarding the presence or absence of
an inflammatory status is not known.
Table 2. Comparison of the levels of proteins (pg/mL) in PPROM women with and without MIAC
Amniotic fluid Cervix Vagina
MIAC (n=21)
Non-MIAC
(n=37) p MIAC (n=11)
Non-MIAC
(n=22) p MIAC (n=11)
Non-MIAC
(n=22) p
IL 8 37 (4-1429) 6 (4-2028) 0.016 239 (12-856) 114 (8-1263) 0.583 62 (4-2522) 109 (10-666) 0.505
IL 18 4 (4-10) 4 (4-8) 0.628 9 (4-22) 14 (4-446) 0.161 17 (8-681) 14 (4-1509) 0.521
CRP 725 (15-4575) 255 (15-2275) 0.016 2970 (15-9147) 569 (15-3920) 0.049 2022 (510-3464) 810 (15-8963) 0.012
RANTES 31 (4-224) 4 (4-1034) 0.012 17 (4-112) 9 (4-141) 0.363 4 (4-45) 4 (4-1106) 0.870
BDNF 54 (10-523) 10 (10-215) 0.039 108 (10-459) 10 (10-209) 0.026 24 (10-99) 10 (10-480) 0.578
MMP 9 2084 (244-37333) 244(244-3759) 0.578 18064(2425-56583) 9538
(1518-68328)
0.651 4194 (244-35816) 7619(1048-111482) 0.149
IFN-c 14 (4-431) 4 (4-288) 0.047 17 (4-57) 4 (4-24) 0.056 4 (4-61) 4 (4-151) 0.601
GM-CSF 15 (4-43) 4 (4-127) 0.004 4 (4-29) 4 (4-54) 0.251 4 (4-85) 8 (4-44) 0.545
sIL-6r 798 (20-6301) 177 (20-10554) 0.112 199 (20-1327) 76 (20-778) 0.513 20 (20-1042) 47 (20-2257) 0.553
Mip 1a 4156 (39-7318) 39 (39-2660) 0.000 1766 (39-4147) 559 (39-6134) 0.143 539 (39-2038) 101 (39-5675) 0.457
IL 6 1763 (20-3527) 69 (20-11980) 0.009 828 (20-6968) 84 (20-616) 0.190 47 (20-16694) 20 (20-2467) 0.578
IL 10 564 (10-9716) 45 (10-1403) 0.018 230 (10-428) 18 (10-715) 0.090 10 (10-142) 10 (10-764) 0.537
IL 12 10 (4-47) 4 (4-28) 0.082 4 (4-10) 4 (4-32) 0.116 4 (4-19) 4 (4-26) 0.734
IL 1b 15 (4-126) 4 (4-641) 0.004 115 (4-789) 23 (4-421) 0.162 46 (4-281) 9 (4-1086) 0.340
TNF b 36 (4-295) 4 (4-214) 0.038 26 (4-81) 4 (4-121) 0.049 4 (4-68) 4 (4-259) 0.805
MCP 1 267 (4-3275) 112 (4-592) 0.060 342 (4-987) 62 (10-380) 0.071 84 (14-530) 41 (4-306) 0.059
TREM 1 991 (98-3873) 98 (98-2727) 0.047 541 (98-1129) 98 (98-1371) 0.014 182 (98-421) 98 (98-3983) 1.000
NT3 534 (4-2409) 42 (4-909) 0.034 400 (4-1262) 64 (4-412) 0.043 123 (4-260) 69 (4-2104) 0.427
Adinopectin 56058(500-220453) 10971(500-106911) 0.062 62850 (500-81899) 20491
(500-99976)
0.106 18971(1700-69448) 13688(500-220672) 0.781
IGFBP1 2476 (461-10000) 2329 (610-8553) 0.967 5522 (3285-10000) 4963
(670-10000)
0.674 7604 (561-10000) 5009 (869-10000) 0.314
IGFBP3 3774 (98-8002) 2119 (98-22476) 0.900 98 (98-902) 98 (98-902) 0.773 98 (98-2129) 177 (98-4753) 0.217
Leptin 1042 (98-8613) 780 (98-20817) 0.200 277 (98-420) 98 (98-540) 0.080 98 (98-402) 98 (98-1137) 0.760
sTNF R1 1505 (156-5791) 336 (156-17583) 0.025 227 (156-1908) 156
(156-1120)
0.079 156 (156-1762) 156 (156-1825) 0.476
MIF 22189 (49-32669) 27258 (49-48836) 0.079 25819 (1153-48827) 27480
(49-40500)
0.948 28696 (49-45117) 25252 (49-45503) 0.597
MIAC: microbial invasion of the amniotic cavity. PPROM: preterm prelabor rupture of membranes. Continuous variables: Mann-Whitney U test, median (range).
doi:10.1371/journal.pone.0085277.t002
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Conclusion
In summary, cervical inflammation mediated by CRP seems to
be a good predictor of MIAC while samples from serum and
vagina seem to add no value. Since there is a limitation with
sample size, further studies must be considered to ratify these
preliminary results.
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